טוען...
Ra‐224 labeling of calcium carbonate microparticles for internal α‐therapy: Preparation, stability, and biodistribution in mice
Internal therapy with α‐emitters should be well suited for micrometastatic disease. Radium‐224 emits multiple α‐particles through its decay and has a convenient 3.6 days of half‐life. Despite its attractive properties, the use of (224)Ra has been limited to bone‐seeking applications because it canno...
שמור ב:
| הוצא לאור ב: | J Labelled Comp Radiopharm |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6001669/ https://ncbi.nlm.nih.gov/pubmed/29380410 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jlcr.3610 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|